Bone Biologics Co. (NASDAQ:BBLG – Get Free Report) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 193,300 shares, an increase of 48.2% from the February 13th total of 130,400 shares. Based on an average daily volume of 218,900 shares, the days-to-cover ratio is presently 0.9 days. Currently, 36.2% of the company’s stock are short sold.
Bone Biologics Stock Performance
Bone Biologics stock opened at $0.83 on Friday. The stock’s 50 day moving average is $0.99 and its 200 day moving average is $1.27. Bone Biologics has a twelve month low of $0.71 and a twelve month high of $4.25.
Bone Biologics Company Profile
Recommended Stories
- Five stocks we like better than Bone Biologics
- With Risk Tolerance, One Size Does Not Fit All
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- What is an Earnings Surprise?
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.